Carbamazepine

Product NDC: 0093-0109
11-digit product format: 000930109
Labeler code: 0093
Product ID: 0093-0109_042aa2c6-95ff-410a-abcf-a8ee79fa96d8
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Carbamazepine
Dosage form: TABLET
Route: ORAL
Labeler: Teva Pharmaceuticals USA, Inc.
Application: ANDA070541
Marketing category: ANDA
Marketing start: 1990-09-30
Marketing end: 2026-07-31
Substance: CARBAMAZEPINE
Active strength: 200 mg/1
Pharmacologic classes: Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
NDC exclude flag: No
Current FDA listing: Yes

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0093-0109		D	Discontinued by firm	2026-07-31
excluded package	package	0093-0109	0093-0109-01	D	Discontinued by firm	2026-07-31
excluded package	package	0093-0109	0093-0109-10	D	Discontinued by firm	2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A070541-001	EPITOL	CARBAMAZEPINE	200MG	TABLET / ORAL	AB		1986-09-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A070541-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A070541-001	EPITOL	200MG	TABLET / ORAL	AB		1986-09-17	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A070541-001	AB	1	`a50c72e98297…`

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Carbamazepine	CARBAMAZEPINE	Bryant Ranch Prepack	ebcffad6-da03-43f4-a75b-7de13e94bb7d	2024-05-30	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 070541 application number: ANDA070541

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
26452c40-1589-928d-2fae-b84a1d1cf183	Product name	9	20251105
2275add5-bc9e-431c-8e27-74c11f3127d5	Product name	1	20200728
7c710123-0208-426b-be07-b37720f2767d	Product name	1	20161206
8448f819-8511-2a70-1d0e-32e16eac918d	Product name	1	20140508
fee3eefd-cade-4e53-89b7-9d28964e1bc7	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0093-0109-01	Carbamazepine	100 in 1 BOTTLE	TABLET	100		28
0093-0109-10	Carbamazepine	1000 in 1 BOTTLE	TABLET	1000		28

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0093-0109-01	EA - Each	0093-0109	1b6c8e15-dc2b-4ae9-92de-bb904c400391	1	2012-07-24
0093-0109-10	EA - Each	0093-0109	6cd8954d-9b9c-4314-bab5-d33413016e6a	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CARBAMAZEPINE	ACTIVE INGREDIENT	33CM23913M	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
CARBAMAZEPINE	ACTIVE MOIETY	33CM23913M	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
ACACIA	INACTIVE INGREDIENT	5C5403N26O	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
ETHYLCELLULOSE (100 MPA.S)	INACTIVE INGREDIENT	47MLB0F1MV	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [TEVA PHARMACEUTICALS USA INC]	16
CARBAMAZEPINE	ACTIVE INGREDIENT	33CM23913M	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
CARBAMAZEPINE	ACTIVE MOIETY	33CM23913M	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CARBAMAZEPINE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]	8
CARBAMAZEPINE	ACTIVE INGREDIENT	33CM23913M	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
CARBAMAZEPINE	ACTIVE MOIETY	33CM23913M	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
ACACIA	INACTIVE INGREDIENT	5C5403N26O	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
ETHYLCELLULOSE (100 MPA.S)	INACTIVE INGREDIENT	47MLB0F1MV	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [MYLAN INSTITUTIONAL INC.]	7
CARBAMAZEPINE	ACTIVE INGREDIENT	33CM23913M	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
CARBAMAZEPINE	ACTIVE INGREDIENT	33CM23913M	CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP]	2
CARBAMAZEPINE	ACTIVE MOIETY	33CM23913M	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
CARBAMAZEPINE	ACTIVE MOIETY	33CM23913M	CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP]	2
ACACIA	INACTIVE INGREDIENT	5C5403N26O	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP]	2
DIETHYL PHTHALATE	INACTIVE INGREDIENT	UF064M00AF	CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP]	2
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CARBAMAZEPINE TABLET [REBEL DISTRIBUTORS CORP]	2
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CARBAMAZEPINE TABLET CARBAMAZEPINE TABLET, CHEWABLE [PHYSICIANS TOTAL CARE, INC.]	2
CARBAMAZEPINE	ACTIVE INGREDIENT	33CM23913M	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
CARBAMAZEPINE	ACTIVE INGREDIENT	33CM23913M	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1
CARBAMAZEPINE	ACTIVE MOIETY	33CM23913M	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
CARBAMAZEPINE	ACTIVE MOIETY	33CM23913M	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
COLLOIDAL SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1
ETHYLCELLULOSE	INACTIVE INGREDIENT	7Z8S9VYZ4B	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
ETHYLCELLULOSE	INACTIVE INGREDIENT	7Z8S9VYZ4B	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARBAMAZEPINE TABLET [CONTRACT PHARMACY SERVICES-PA]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CARBAMAZEPINE TABLET [STAT RX USA LLC]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
33CM23913M	CARBAMAZEPINE	298-46-4	CARBAMAZEPINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308979	carBAMazepine 200 MG Oral Tablet	PSN	ebcffad6-da03-43f4-a75b-7de13e94bb7d	103
308979	carbamazepine 200 MG Oral Tablet	SCD	ebcffad6-da03-43f4-a75b-7de13e94bb7d	103
308973	carBAMazepine 100 MG Chewable Tablet	PSN	bfd63965-56e6-4af7-b7ef-45a5105d4d35	28
308979	carBAMazepine 200 MG Oral Tablet	PSN	bfd63965-56e6-4af7-b7ef-45a5105d4d35	28
308973	carbamazepine 100 MG Chewable Tablet	SCD	bfd63965-56e6-4af7-b7ef-45a5105d4d35	28
308979	carbamazepine 200 MG Oral Tablet	SCD	bfd63965-56e6-4af7-b7ef-45a5105d4d35	28
308973	carBAMazepine 100 MG Chewable Tablet	PSN	f38feadf-3fa4-430c-99ed-374023f8132c	2
308979	carBAMazepine 200 MG Oral Tablet	PSN	25cca2b1-9020-4d8a-bc22-b8063e57f9e1	2
308979	carBAMazepine 200 MG Oral Tablet	PSN	f38feadf-3fa4-430c-99ed-374023f8132c	2
308973	carbamazepine 100 MG Chewable Tablet	SCD	f38feadf-3fa4-430c-99ed-374023f8132c	2
308979	carbamazepine 200 MG Oral Tablet	SCD	25cca2b1-9020-4d8a-bc22-b8063e57f9e1	2
308979	carbamazepine 200 MG Oral Tablet	SCD	f38feadf-3fa4-430c-99ed-374023f8132c	2
308979	carBAMazepine 200 MG Oral Tablet	PSN	8e06995c-26c9-4ef3-9421-16a2360db628	1
308979	carBAMazepine 200 MG Oral Tablet	PSN	988cce8b-eb9f-4bf7-85bc-a736575d98b1	1
308979	carbamazepine 200 MG Oral Tablet	SCD	8e06995c-26c9-4ef3-9421-16a2360db628	1
308979	carbamazepine 200 MG Oral Tablet	SCD	988cce8b-eb9f-4bf7-85bc-a736575d98b1	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0093-0109-01	00093010901	100 TABLET in 1 BOTTLE (0093-0109-01)	100 tablet	1990-09-30	2026-06-30	No	No	Current
0093-0109-10	00093010910	1000 TABLET in 1 BOTTLE (0093-0109-10)	1000 tablet	1990-09-30	2026-07-31	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CARBAMAZEPINE TABLETS, USP 200 mg CARBAMAZEPINE TABLETS, USP (CHEWABLE) 100 mg Rx only	Bryant Ranch Prepack	2024-05-30	HUMAN PRESCRIPTION DRUG LABEL	103
CARBAMAZEPINE TABLETS, USP 200 mg CARBAMAZEPINE TABLETS, USP (CHEWABLE) 100 mg Rx only	Teva Pharmaceuticals USA, Inc.	2024-01-01	HUMAN PRESCRIPTION DRUG LABEL	28
CARBAMAZEPINE TABLETS USP, 200 mg / CARBAMAZEPINE TABLETS USP (CHEWABLE), 100 mg 0109 0778 Rx only	NCS HealthCare of KY, LLC dba Vangard Labs	2023-09-13	HUMAN PRESCRIPTION DRUG LABEL	17
CARBAMAZEPINE TABLETS USP, 200 mg/CARBAMAZEPINE TABLETS USP (CHEWABLE), 100 mg Rx only	Mylan Institutional Inc.	2020-12-21	HUMAN PRESCRIPTION DRUG LABEL	17
CARBAMAZEPINE TABLETS USP 200 mg Rx only	Rebel Distributors Corp	2011-01-04	HUMAN PRESCRIPTION DRUG LABEL	2
Carbamazepine - Physicians Total Care, Inc.	Physicians Total Care, Inc.	2010-05-10	HUMAN PRESCRIPTION DRUG LABEL	2
CARBAMAZEPINE TABLETS USP, 200 mg/CARBAMAZEPINE CHEWABLE TABLETS USP, 100 mg 0109 0778 Rx only	STAT RX USA LLC	2010-03-02	HUMAN PRESCRIPTION DRUG LABEL	1
CARBAMAZEPINE TABLETS USP, 200 mg/CARBAMAZEPINE CHEWABLE TABLETS USP, 100 mg 0109 0778 Rx only	Contract Pharmacy Services-PA	2010-02-24	HUMAN PRESCRIPTION DRUG LABEL	1